Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cannabis Bioscience International Holdings Inc CBIH

Cannabis Bioscience International Holdings, Inc. provides educational and other services to the cannabis industry. The Company provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The Company’s segments include Pharmacology University Business and Alpha Research Business. Through the Pharmacology University Business, the Company provides knowledge and promotes professionalism in the rapidly growing worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. These trials have included drugs relating to diseases in the areas of asthma, allergies, renal disorders, neurology disorders, cardiac and vascular disorders and others.


OTCPK:CBIH - Post by User

Post by averagepennieson Aug 24, 2023 7:48am
58 Views
Post# 35603286

FINRA Announces Approval for Corporate Name Change

FINRA Announces Approval for Corporate Name Change

HOUSTON, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Bioscience International Holdings (the “Company”) a diversified medical and educational company with a particular focus on traditional clinical trials and cannabinoids research, is excited to announce that FINRA (Financial Industry Regulatory Authority, Inc.) has approved the corporate name change from “China Infrastructure Construction Corp.” to “Cannabis Bioscience International Holdings” as well as its ticker symbol change from “CHNC” to “CBIH”.

CBIH’s treasurer Henry Levinski said, “Adopting to a new stock ticker symbol is a reflection of the progress we have made in our strategy of reinventing/rebranding our company since our merger. This further establishes CBIH as a diversified Houston-based company with a clear identity, instead of the two-fold confusion that the former generated in name and ticker symbol. In the next weeks, brand identity that reflects this change will be announced.”

No action is required by the Company’s current shareholders as a result of this change, and it has been reported that from August 17 to today the change in the ticker symbol should have been made effective on the different broker’s platforms.

https://www.globenewswire.com/news-release/2023/08/21/2728710/0/en/FINRA-Announces-Approval-for-Corporate-Name-Change-From-China-Infrastructure-Construction-Corp-to-Cannabis-Bioscience-International-Holdings-and-Ticker-Symbol-Change-from-CHNC-to-C.html

Bullboard Posts
Next >>